Drug Profile
Research programme: anticancer therapeutics - LeadInvent/Sphaera Pharma
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator LeadInvent; Sphaera Pharma
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Cancer(Combination therapy) in India
- 05 Aug 2016 Early research in Cancer (Combination therapy) in India (unspecified route)